Skip to content

Using a blood test alongside body fat measurements for obesity risk prediction to improve pregnancy outcomes

Using a blood test alongside body fat measurements for obesity risk prediction to improve pregnancy outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN13935752
Enrollment
900
Registered
2026-03-06
Start date
2022-04-28
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy outcomes Pregnancy and Childbirth

Interventions

Data from the SHAPES study will be used, with serum samples from 885 participants. Biochemical measures will include a traditional lipid panel, adiponectin, gamma-glutamyl transferase, sex-hormone bin

Sponsors

Newcastle upon Tyne Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant with a singleton pregnancy 2. Presenting to a scan at 11+2 to 14+1 weeks gestation 3. =18 years of age 4. Planned to deliver locally

Exclusion criteria

Exclusion criteria: 1. Unable/unwilling to give informed consent to participate 2. Women with a miscarriage prior to the 12-week scan, or threatened miscarriage identified on the patient's records as a visit to the Early Pregnancy Assessment Clinic (EPAC) or A&E relating to their pregnancy with an adverse outcome, will be excluded. 3. Women having twins (or higher order pregnancy) - we will not know whether women have a multiple pregnancy until their 12-week scan appointment (after consent). Any women identified as having a multiple pregnancy at the 12-week scan will be excluded. They will still receive the thank-you gift of pregnancy photographs.

Countries

England, United Kingdom

Contacts

Public ContactJanine Smith
hello@janine-smith.com+44 (0)191 282 0540

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 20, 2026